Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 142Terminated 24Unknown 11Withdrawn 7Active not recruiting 4Recruiting 2Suspended 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Lymphoid 2Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 10Hematologic Neoplasms 7Leukemia 6Leukemia, Lymphocytic, Chronic, B-Cell 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 4Neoplasms 3Immunoblastic Lymphadenopathy 3Recurrence 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Pain, Intractable 1Neurotoxicity Syndromes 1Neoplasms by Histologic Type 1Neoplasm, Residual 1Multiple Myeloma 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia-Lymphoma, Adult T-Cell 1

Interventions

RFB4(dsFv)-PE38 recombinant immunotoxin 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Dendritic Cell Sarcoma, Interdigitating × Other hematologic neoplasm × Clear all
NCT00077493 2007-12-28

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

MedImmune LLC

Phase 1 Suspended
95 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡